Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom = The role of PSMA PET-CT in patients with metastatic prostate cancer
Prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) imaging for the localization of prostate cancer is increasingly available in Germany. The advances and limitations in different disease stages are reviewed. As the clinical relevance of oligometastati...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
17 January 2018
|
| In: |
Der Radiologe
Year: 2018, Jahrgang: 58, Heft: 3, Pages: 226-232 |
| ISSN: | 1432-2102 |
| DOI: | 10.1007/s00117-018-0358-8 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1007/s00117-018-0358-8
|
| Verfasserangaben: | J. von Hardenberg, K.-A. Büsing, P. Nuhn, M. Ritter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662884796 | ||
| 003 | DE-627 | ||
| 005 | 20230426154249.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190405s2018 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00117-018-0358-8 |2 doi | |
| 035 | |a (DE-627)1662884796 | ||
| 035 | |a (DE-599)KXP1662884796 | ||
| 035 | |a (OCoLC)1341207898 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hardenberg, Jost von |d 1982- |e VerfasserIn |0 (DE-588)1020494328 |0 (DE-627)688149278 |0 (DE-576)360578241 |4 aut | |
| 245 | 1 | 4 | |a Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom |b = The role of PSMA PET-CT in patients with metastatic prostate cancer |c J. von Hardenberg, K.-A. Büsing, P. Nuhn, M. Ritter |
| 246 | 3 | 1 | |a The role of PSMA PET-CT in patients with metastatic prostate cancer |
| 264 | 1 | |c 17 January 2018 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.04.2019 | ||
| 520 | |a Prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) imaging for the localization of prostate cancer is increasingly available in Germany. The advances and limitations in different disease stages are reviewed. As the clinical relevance of oligometastatic disease in primary cancer detected by PSMA PET-CT imaging is not yet completely understood, it should only be used in clinical trials. In recurrent prostate cancer after therapy with curative intent, PSMA PET-CT shows encouraging potential for the planning of salvage therapy. In metastatic castration-resistant prostate cancer evidence for its use is not available. | ||
| 650 | 4 | |a Castration-resistant prostate cancer (CRPC) | |
| 650 | 4 | |a Kastrationsresistentes Prostatakarzinom (CRPC) | |
| 650 | 4 | |a Oligometastases | |
| 650 | 4 | |a Oligometastasierung | |
| 650 | 4 | |a Primärdiagnostik | |
| 650 | 4 | |a Primary diagnostic | |
| 650 | 4 | |a Prostatectomy | |
| 650 | 4 | |a Prostatektomie | |
| 650 | 4 | |a radical | |
| 650 | 4 | |a radikale | |
| 650 | 4 | |a Recurrence | |
| 650 | 4 | |a Rezidivdiagnostik | |
| 700 | 1 | |a Büsing, Karen-Anett |d 1970- |e VerfasserIn |0 (DE-588)123814634 |0 (DE-627)706436032 |0 (DE-576)293891222 |4 aut | |
| 700 | 1 | |a Nuhn, Philipp |d 1981- |e VerfasserIn |0 (DE-588)136112951 |0 (DE-627)694090808 |0 (DE-576)30083909X |4 aut | |
| 700 | 1 | |a Ritter, Manuel |d 1979- |e VerfasserIn |0 (DE-588)1030329915 |0 (DE-627)73508436X |0 (DE-576)378128256 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Der Radiologe |d Berlin : Springer, 1996 |g 58(2018), 3, Seite 226-232 |h Online-Ressource |w (DE-627)25463916X |w (DE-600)1463036-9 |w (DE-576)074531832 |x 1432-2102 |7 nnas |a Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom = The role of PSMA PET-CT in patients with metastatic prostate cancer |
| 773 | 1 | 8 | |g volume:58 |g year:2018 |g number:3 |g pages:226-232 |g extent:7 |a Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom = The role of PSMA PET-CT in patients with metastatic prostate cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00117-018-0358-8 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190405 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1030329915 |a Ritter, Manuel |m 1030329915:Ritter, Manuel |d 60000 |d 63100 |e 60000PR1030329915 |e 63100PR1030329915 |k 0/60000/ |k 1/60000/63100/ |p 4 |y j | ||
| 998 | |g 136112951 |a Nuhn, Philipp |m 136112951:Nuhn, Philipp |d 60000 |d 63100 |e 60000PN136112951 |e 63100PN136112951 |k 0/60000/ |k 1/60000/63100/ |p 3 | ||
| 998 | |g 123814634 |a Büsing, Karen-Anett |m 123814634:Büsing, Karen-Anett |d 60000 |d 62900 |e 60000PB123814634 |e 62900PB123814634 |k 0/60000/ |k 1/60000/62900/ |p 2 | ||
| 998 | |g 1020494328 |a Hardenberg, Jost von |m 1020494328:Hardenberg, Jost von |d 60000 |d 63100 |e 60000PH1020494328 |e 63100PH1020494328 |k 0/60000/ |k 1/60000/63100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1662884796 |e 3418296696 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["ger"],"title":[{"title_sort":"Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom","subtitle":" = The role of PSMA PET-CT in patients with metastatic prostate cancer","title":"Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom"}],"titleTranslated":[{"translated":"The role of PSMA PET-CT in patients with metastatic prostate cancer"}],"person":[{"role":"aut","given":"Jost von","display":"Hardenberg, Jost von","family":"Hardenberg"},{"family":"Büsing","display":"Büsing, Karen-Anett","role":"aut","given":"Karen-Anett"},{"family":"Nuhn","role":"aut","given":"Philipp","display":"Nuhn, Philipp"},{"family":"Ritter","display":"Ritter, Manuel","role":"aut","given":"Manuel"}],"name":{"displayForm":["J. von Hardenberg, K.-A. Büsing, P. Nuhn, M. Ritter"]},"note":["Gesehen am 05.04.2019"],"relHost":[{"disp":"Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem Prostatakarzinom = The role of PSMA PET-CT in patients with metastatic prostate cancerDer Radiologe","id":{"issn":["1432-2102"],"zdb":["1463036-9"],"eki":["25463916X"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 13.06.2022"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Zeitschrift für bildgebende Verfahren, Radioonkologie, Nuklearmedizin"},{"title":"Organ vom: Berufsverband der Deutschen Radiologen e.V."},{"title":"Organ der Arbeitsgemeinschaft Berufsverbände Medizinische Radiologie"}],"origin":[{"publisher":"Springer ; Springer","dateIssuedDisp":"[1996?-2022]","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY"}],"recId":"25463916X","title":[{"title_sort":"Radiologe","title":"Der Radiologe","subtitle":"Zeitschrift für diagnostische und interventionelle Radiologie, Radioonkologie, Nuklearmedizin : Organ des Berufsverbands der Deutschen Radiologen e.V."}],"part":{"volume":"58","year":"2018","text":"58(2018), 3, Seite 226-232","issue":"3","extent":"7","pages":"226-232"},"language":["ger"],"pubHistory":["Volume 36, issue 1 (January 1996) [?]-volume 62, issue 5 (May 2022)"]}],"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.1007/s00117-018-0358-8"],"eki":["1662884796"]},"recId":"1662884796","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"17 January 2018"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a HARDENBERGROLLEDESPS1720 | ||